Correlation Between Madrigal Pharmaceuticals and Invivyd

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Invivyd at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Invivyd into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Invivyd, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Invivyd and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Invivyd. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Invivyd.

Diversification Opportunities for Madrigal Pharmaceuticals and Invivyd

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Madrigal and Invivyd is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Invivyd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invivyd and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Invivyd. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invivyd has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Invivyd go up and down completely randomly.

Pair Corralation between Madrigal Pharmaceuticals and Invivyd

Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.89 times more return on investment than Invivyd. However, Madrigal Pharmaceuticals is 1.12 times less risky than Invivyd. It trades about 0.21 of its potential returns per unit of risk. Invivyd is currently generating about -0.13 per unit of risk. If you would invest  25,934  in Madrigal Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  6,885  from holding Madrigal Pharmaceuticals or generate 26.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Madrigal Pharmaceuticals  vs.  Invivyd

 Performance 
       Timeline  
Madrigal Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain technical and fundamental indicators, Madrigal Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.
Invivyd 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Invivyd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Invivyd is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Madrigal Pharmaceuticals and Invivyd Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Madrigal Pharmaceuticals and Invivyd

The main advantage of trading using opposite Madrigal Pharmaceuticals and Invivyd positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Invivyd can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invivyd will offset losses from the drop in Invivyd's long position.
The idea behind Madrigal Pharmaceuticals and Invivyd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Transaction History
View history of all your transactions and understand their impact on performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments